[1Q20 VS. 4Q19] [1Q20 VS. 1Q19] FX: THB/USD 31.1053 30.0127 31.3204 Sales Revenue, THB 3,259.7 2,902.4 +12.3% 3,113.9 +4.7% [ Sales Revenue, USD $104.8 $96.7 +8.4% $99.4 +5.4% ] Cost of Sales 2,477.7
Difference Percentage associate Management benefit expenses (3.73) (4.51) (078) (82.71) Financial cost (0.31) (0.03) (0.28) (1033.33) Share of loss in associates - (15.06) - - Total expenses (16.97) (32.57
income 93,154 25.49% 11,509 5.86% 81,645 709.40% Total revenues 365,424 100.00% 196,323 100.00% 169,101 86.13% Cost of sales (198,397) 54.29% (126,154) 64.26% (72,243) 57.27% Cost of services (30,098) 8.24
diminution in value - 0.00% 50,000 10.53% (50,000) 100.00% Finance cost (19,689) 3.14% (8,318) 1.75% (11,371) 136.70% Share of profit from investment in associate 777 0.12% 433 0.09% 344 79.45% Profit (loss
or 27.27 percent decreased by following details; Cost of goods sold as amount of 282.16 Million Baht as 99.25 Million Baht decreased or 26.02 percent when compared to same period of previous year of
quarter of 2020 were Baht 177 million, a decrease of 17 percent compared to the third quarter of the previous year, mainly due to a decrease in the market share of the Company. 1.2 Fee and Service income
) Separate financial statements 2020 2019 % Change Sales and Service Income 1,806.35 2,055.48 (12) Other income 51.75 17.71 192 Less Cost of Sales and Services 1,496.81 1,647.83 (9) Selling and Administrative
the vote of the shareholders having a conflict of interest. As the Company will pay for acquired assets with share of WCIH, it is considered as two transactions; the acquisition and disposition of
Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th 3-Month Period Ending March 31st 2020 2019 Change MB % MB % MB % Cost of Sales 35.76
items. 1.2 Expenses 1.2.1 Cost of services In Q1/2020, Cost of services was of Bt424.5 million, increased of Bt36.8 million or 9.5%(y-o-y), which was an increase of 1) depreciation and amortization of